Be prepared to hear this type of announcement from all corners of medicare reimbursement. It happened to our procedure codes last year and this looks to be CMS's approach to cost containment.
That said, BEAT is starting to look attractive from a price valuation. It now heads to the top of my list of device makers that is topped by BABY.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.